Figure 4From: A randomized, double-blind, placebo-controlled study of the effect of ezetimibe on glucose metabolism in subjects with type 2 diabetes mellitus and hypercholesterolemiaPercent change from baseline to 24Â weeks in lipid parameters (FAS). No patient had triglyceride level >400Â mg/dL after allocation.Back to article page